Infections in the Elderly

Critical Care Clinics

Volumn 29, Issue 3, 2013, Pages 757-774

  Heppner, Hans Jürgen ^a,b   Cornel, Sieber ^b   Peter, Walger ^c   Philipp, Bahrmann ^a,b   Katrin, Singler ^a,b  

^a KLINIKUM NÜRNBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Johanniter Krankenhaus   (Germany)

Author keywords

Elderly; Functional decline; Geriatric; Immune senescence; Infections; Pneumonia; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBAMAZEPINE; CD16 ANTIGEN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; DIGOXIN; FIDAXOMYCIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; MACROLIDE; METRONIDAZOLE; PHENYTOIN; PROCALCITONIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN; WARFARIN;

AGING; ANTIBIOTIC THERAPY; ASPERGILLOSIS; ASPIRATION PNEUMONIA; BARTHEL INDEX; BLOOD CELL COUNT; BLOODSTREAM INFECTION; CANDIDIASIS; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFUSION; DAILY LIFE ACTIVITY; DELIRIUM; DIARRHEA; DIZZINESS; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG ERUPTION; FRAIL ELDERLY; GERIATRIC DISORDER; HALLUCINATION; HEALTH CARE SYSTEM; HEART ARRHYTHMIA; HOSPITAL INFECTION; HUMAN; IMMUNE SYSTEM; INFECTION; LEUKOCYTE COUNT; MONOTHERAPY; MYCOSIS; NAUSEA; OTOTOXICITY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS INFECTION; QUALITY OF LIFE; REVIEW; SARCOPENIA; SEIZURE; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; SOMNOLENCE; STAPHYLOCOCCUS INFECTION; STRESS; T LYMPHOCYTE; THORAX RADIOGRAPHY; URINARY TRACT INFECTION; VOMITING;

ELDERLY; FUNCTIONAL DECLINE; GERIATRIC; IMMUNE SENESCENCE; INFECTIONS; PNEUMONIA; SEPSIS;

ACTIVITIES OF DAILY LIVING; ACUTE DISEASE; AGED; AGED, 80 AND OVER; AGING; ANTI-INFECTIVE AGENTS; CASE MANAGEMENT; CHRONIC DISEASE; COMMUNICABLE DISEASES; COMORBIDITY; DELIRIUM; DISEASE PROGRESSION; FRAIL ELDERLY; HUMANS; PROGNOSIS; RISK ASSESSMENT; SARCOPENIA;

EID: 84880014614     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2013.03.016     Document Type: Review

References (124)

1. Gould S.J. Book of the worms. Leonardo's moutain of claims and zhediet of worms 1998, Harvard Univ Pr, New York.
2. Thurston A.J. Of blood, inflammation and gunshot wounds: the history of the control of sepsis. Aust NZ J Surg 2000, 70:855-861.
3. Hurlbert R. Chapter 1: a brief history of microbiology. Microbiology 101/102 internet text [online]. 1999. Available at: Accessed December 19, 2012. http://www.slic2.wsu.edu:82/hurlbert/micro101/pages/Chap1.html.
4. De Costa C.M. "The contagiousness of childbed fever": a short history of puerperal sepsis and its treatment. Med J Aust 2002, 177:668-671.
5. Baron R.M., Baron M.J., Perrella M.A. Pathobiology of sepsis: are we still asking the same questions?. Am J Respir Cell Mol Biol 2006, 34:129-134.
6. Francoeur J.R. Joseph Lister: surgeon scientist (1827-1912). JInvest Surg 2000, 13:129-132.
7. Sandiumenge A., Diaz E., Bodí M., et al. Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy". Intensive Care Med 2003, 29(6):876-883.
8. Ehrlich P. The Therapia sterilisans magna. Lancet 1913, 16:445-451.
9. Marrie T.J., Haldane E.V., Faulkner R.S., et al. Community-acquired pneumonia requiring hospitalization. Is it different in the elderly?. JAm Geriatr Soc 1985, 33:671-680.
10. Osler W. Principles and practice of medicine designed for the use of practitioners and students of medicine 2004, Young J. Pentland, London, p. 108. 3rd edition.
11. Lang E., Gassmann K.G. Pro Aging statt Anti-Aging-was ist da anders?. Euro J Ger 2005, 7:190-193.
12. Castle S.C. Impact of age-related immune dysfunction on risk of infections. ZGerontol Geriatr 2000, 33:341-349.
13. Rozzini R., Sabatini T., Trabutchi M. Assessment of pneumonia in Elderly patients. JAm Geriatr Soc 2007, 55:308-317.
14. Kollef M.H., Shorr A., Tabak Y.P., et al. Epidemiology and outcomes of health-care-associated Pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005, 128:3854-3862.
15. El-Solh A.A., Pietrantoni C., Bhat A., et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003, 167:1650-1654.
16. Tockman M.S. Aging of the respiratory system. Principles of geriatric medicine and gerontology 1994, 499-508. McGraw-Hill, New York. W.R. Hazzard, R. Andres, E.L. Bierman (Eds.).
17. French D.D., Cambell R.R., Rubenstein L.Z. Long-stay nursing home residents' hospitalizations in the VHA: the potential impact of aligning financial incentives on hospitalizations. JAm Med Dir Assoc 2008, 9:499-503.
18. Vergidis P., Hamer D.H., Meydani S.N., et al. Patterns of antimicrobal use for respiratory tract infections in older residents of long-term care facilities. JAm Geriatr Soc 2011, 59:1093-1098.
19. Álvarez-Rodrígez L., López-Hoyos M., Munóz-Cacho P. Aging is associated with circulation cytocine dysregulation. Cell Immunol 2012, 273:124-132.
20. Grubeck-Loebenstein B., Wick G. The aging of the immune system. Adv Immunol 2002, 80:243-284.
21. Butcher S.K., Chahal A., Nayak L., et al. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. JLeukoc Biol 2001, 70:881-886.
22. Aspinall R., Del Giudice D., Effros R.B., et al. Challenges for vaccination in the elderly. Immun Ageing 2007, 11:4-9.
23. Carbon C. Optimal treatment strategies for community-acquired pneumonia: high-risk patients (geriatric and with comorbidity). Chemotherapy 2001, 47(Suppl 4):19-25.
24. Marrie T.J. Pneumonia in the elderly. Curr Opin Pulm Med 1996, 2(3):192-197.
25. Sieber C. Frailty. Ther Umsch 2008, 65:421-426.
26. Fried L., Tangen C.M., Walston J., et al. Frailty in older adults: evidence of a phenotype. JGerontol A Biol Sci Med Sci 2001, 56:M146-M156.
27. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39(4):412-423.
28. Barbieri M., Ferucci L., Rango E., et al. Chronic inflammation and the effect of IGF-1 on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 2003, 284:E481-E487.
29. Leng S., Chaves P., Koenig K., et al. Serum interleukin-6 and haemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. JAm Geriatr Soc 2002, 50:1268-1271.
30. Heppner H.J., Bauer J.M., Sieber C.C., et al. Laboratory aspects relating to the detection and prevention of frailty. Int J Prev Med 2010, 1:149-157.
31. Erschler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000, 51:245-270.
32. Bruunsgaard H., Ladelund S., Pedersen A.N., et al. Predicting death from tumor necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 2003, 132:24-31.
33. Dumke B.R., Lees S.J. Age-related impairment of T-cell induced sceletal muscle precursor cell function. Am J Physiol Cell Physiol 2011, 300:C1226-C1233.
34. von Haeling S., Morley J.E., Anker S.D. An overview of sarcopenia: facts and numbers of prevalence and clinical impact. JCachexia Sarcopenia Muscle 2010, 1:129-133.
35. Rosenberg I.H. Sarcopenia: origins and clinical relevance. Clin Geriatr Med 2011, 27(3):337-339.
36. Landi F., Liperoti R., Fusco D., et al. Sarcopenia and mortality among older nursing home residents. JAm Med Dir Assoc 2012, 13:121-126.
37. Strüchler H.P. Abklärung und Antibiotikatherapie von Infektionen in der Hausarztpraxis. Schweiz Med Wochenschr 2000, 130:1437-1446.
38. Waalen J. Is older colder or colder older?. JGerontol A Biol Sci Med Sci 2011, 66:487-492.
39. Blatteis C.M. Age-dependent changes in temperature regulation - a mini review. Gerontology 2012, 58:289-295.
40. Mikkelsen M.E., Gaieski D.F. Antibiotics in sepsis: timing, appropriateness, and (of course) timely recognition of appropriateness. Crit Care Med 2011, 39:2184-2186.
41. Yoshikawa T.T., Norman D.C. Fever and infection in nursing homes. JAm Geriatr Soc 2000, 44:74-82.
42. Christ M., Heppner H.J. Der COPD Patient mit Atemnot. Ther Umsch 2009, 66:657-664.
43. Lim W.S., Baudouin S.V., George R.C., et al. BTS guidelines for the management ofcommunity acquired pneumonia in adults: update 2009. Thorax 2009, 64(Suppl 3):iii1-iii55.
44. Hoffken G., Lorenz J., Kern W., et al. S3-guideline on ambulant acquired pneumonia and deep airway infections. Pneumologie 2009, 63:e1-e68.
45. Sorde R., Falco V., Lowak M., et al. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch Intern Med 2011, 171(2):166-172.
46. Solh El A.A., Aquilina A.T., Gunen H., et al. Radiographic resolution of community-acquired bacterial pneumonia in the elderly. JAm Geriatr Soc 2004, 52(2):224-229.
47. Delerme S., Ray P. Acute respiratory failure in the elderly: diagnosis and prognosis. Age Ageing 2008, 37:251-257.
48. Lippi G., Meschi T., Cervellin G. Inflammatory biomarker fort the diagnosis, monitoring and follow-up of the community-acquired pneumonia: clinical evidence and perspectives. Eur J Intern Med 2011, 22(5):460-465.
49. Gilbert D.N. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 2011, 52:S346-S350.
50. Krüger S., Ewig S., Marre R., et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008, 31:349-355.
51. Heppner H.J., Bertsch T., Alber B. Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia-a clinical observation in geriatric patients. Gerontology 2010, 56(4):385-389.
52. Müller F., Christ-Crain M., Bregenzer T., et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest 2010, 138(1):121-129.
53. Inouye S.K. The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994, 97:278-288.
54. Lipowski Z.J. Update on delirium. Psychiatr Clin North Am 1992, 15:335-346.
55. Weinrich S., Sarna L. Delirium in the older person with cancer. Cancer 1994, 74:2079-2091.
56. Ókeeffe S.T. Clinical subtypes of delirium in the elderly. Dement Geriatr Cogn Disord 1999, 10:380-385.
57. S3-Leitlinie CAP, 2009'er update: AWMF online. Available at: Accessed December 20, 2012. http://www.awmf.org/uplouds/tx.
58. Eriksson I., Gustafson Y., Fagerström L., et al. Urinary tract infection in veryoldwomen is associated with delirium. Int Psychogeriatr 2011, 23(3):496-502.
59. Han J.H., Wilson A., Ely E.W. Delerium in the older emergency department patient: a quiet epidemic. Emerg Med Clin North Am 2010, 28(3):611-631.
60. Singler K., Singler B., Heppner H.J. Akute Verwirrtheit im Alter. Dtsch Med Wochenschr 2011, 136:681-684.
61. Quinn T.J., McArthur K., Ellis G., et al. Functional assessment in older people. BMJ 2011, 343:d4681-d4688.
62. Schuhmacher J.G. Emergency medicine and older adults: continuing challenges and opportunities. Am J Emerg Med 2005, 23:556-560.
63. Cooper R., Kuh D., Hardy R., et al. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ 2010, 341:c4467.
64. Stott D.J., Langhorne P., Knight P.V. Multidisciplinary care for elderly people in the community. Lancet 2008, 371:699-700.
65. Lim W.S., van der Eerden M.M., Laing R., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
66. Community Acquired Pneumonia in Adults Guideline Group. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009;64(Suppl III):1-55.
67. Fine M.J., Orloff J.J., Arsiumi D., et al. Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med 1990, 88(5N):1N-8N.
68. Malin A. Pneumonia in old age. Chron Respir Dis 2011, 8:207-210.
69. Ott S.R., Lode H. Diagnostik und Therapie der Aspirations pneumonie. Dtsch Med Wochenschr 2006, 131:624-628.
70. Loeb M. Community acquired pneumonia. Clin Evid 2003, 10:1724-1737.
71. Trivalle C., Martin E., Martel P., et al. Group B streptococcal bacteraemia in the elderly. JMed Microbiol 1998, 47:649-652.
72. George J., Sturegess I., Purewal S., et al. Improving quality and value in health care for frail older people. Qual Ageing 2007, 8:4-9.
73. Abrutyn E., Mossey J., Berlin J.A., et al. Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women?. Ann Intern Med 1994, 120:827-833.
74. Woodford H.J., George J. Diagnosis and management of urinary tract infections in hospitalized older people. JAm Geriatr Soc 2009, 57:107-114.
75. Richardson J.P. Bacteremia in the elderly. JGen Intern Med 1993, 8:89-92.
76. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000. Am J Infect Control 2000, 28(6):429-448.
77. Burlaud A., Mathieu D., Falissard B., et al. Mortality and bloodstream infections in geriatrics units. Arch Gerontol Geriatr 2010, 51(3):e106-e109.
78. Weerusuriya N., Snape J. Oesophageal candidiasis in elderly patients: risk factors, prevention and management. Drugs Aging 2008, 25:119-130.
79. Fraisse T., Cruzet J., Lachaud L., et al. Candiduria in those over 85 years old: a retrospective study of 73 patients. Intern Med 2011, 50:1935-1940.
80. Martin E.S., Elewski B.E. Cutaneous fungal infections in the elderly. Clin Geriatr Med 2002, 18:59-75.
81. Lamagni T.L., Evans B.G., Shigematsu M., et al. Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9). Epidemiol Infect 2001, 126:397-414.
82. El Solh A.A., Akinnusi M.E., Alsawalha L.N., et al. Outcome of septic shock in older adults after implementation of the sepsis "bundle". JAm Geriatr Soc 2008, 56:272-278.
83. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. NEngl J Med 2003, 348:1546-1554.
84. Martin G.S., Mannino D.M., Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006, 34:15-21.
85. Kollef M.H., Micek S.T. Using protocols to improve patient outcomes in the intensive care unit: focus on mechanical ventilation and sepsis. Semin Respir Crit Care Med 2010, 31:19-30.
86. Heppner H.J., Singler K., Kwetkat A., et al. Do clinical guidelines improve management of sepsis in critically ill elderly patients? A before-and-after study of the implementation of a sepsis protocol. Wien Klin Wochenschr 2012, 124:692-698.
87. Bochud P.Y., Glauser M.P., Calandra T. Antibiotics in sepsis. Intensive Care Med 2001, 27:S33-S48.
88. Abad C.L., Kumar A., Safdar N. Antimicrobial therapy of sepsis and septic shock-when are two drugs better than one?. Crit Care Clin 2011, 27:e1-e27.
89. Pinder M., Bellomo R., Lipman J. Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intensive Care 2002, 30(2):134-144.
90. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
91. Green D.L. Selection of an empiric antibiotic regimen for hospital-acquired pneumonia using a unit and culture type specific antibiogram. JIntensive Care Med 2005, 20:296-301.
92. Thiem U., Heppner H.J., Pientka L. Elderly patients with community-acquired pneumonia: optimal treatment strategies. Drugs Aging 2011, 28:519-537.
93. Dong K., Quan D.J. Appropriately assessing renal function for drug dosing. Nephrol Nurs J 2010, 37(3):304-308.
94. Murphree D.D., Thelen S.M. Chronic kidney disease in primary care. JAm Board Fam Med 2010, 23(4):542-550.
95. Olyaei A.J., Bennett W.M. Drug dosing in the elderly patients with chronic kidney disease. Clin Geriatr Med 2009, 25(3):459-527.
96. Venkatesan P., Gladman J., Macfarlane J.T., et al. Ahospital study of community acquired pneumonia in the elderly. Thorax 1990, 45:254-258.
97. Fernandez-Sabe N., Carratala J., Roson B., et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine 2003, 82:159-169.
98. Martin C.M., Kunin C.M., Gottlieb L.S., et al. Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza. Arch Intern Med 1959, 103:532-542.
99. Niederman M.S., Ahmed Q.A. Community-acquired pneumonia in elderly patients. Clin Geriatr Med 2003, 19(1):101-120.
100. File T.M. Community-acquired pneumonia. Lancet 2003, 362(9400):1991-2001.
101. Welte T., Kohnlein T. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin Respir Crit Care Med 2009, 30(2):127-135.
102. Kumar A., Zarychanski R., Light B., et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 2010, 38:1773-1785.
103. Kumar A., Safdar N., Kethireddy S., et al. Asurvival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study. Crit Care Med 2010, 38:1651-1664.
104. Garnacho-Montero J., Aldabo-Pallas T., Garnacho-Montero C., et al. Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care 2006, 10:R111.
105. Pines J.M., Localio A.R., Hollander J.E., et al. The impact of emergency department crowding measures on time to antibiotics for patients with community-acquired pneumonia. Ann Emerg Med 2007, 50:510-516.
106. Pines J.M., Morton M.J., Datner E.M., et al. Systematic delays in antibiotic administration in the emergency department for adult patients admitted with pneumonia. Acad Emerg Med 2006, 13:939-945.
107. Waterer G.W., Kessler L.A., Wunderink R.G. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest 2006, 130:11-15.
108. Herring A.R., Williamson J.C. Principles of antimicrobial use in older adults. Clin Geriatr Med 2007, 23(3):481-497.
109. Zenilman J. Infection and Immunity. Oxford American Handbook of Geriatric Medicine 2010, 642. Oxford University Press. S.C. Durso (Ed.).
110. Stahlmann R., Lode H. Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging 2010, 27(3):193-209.
111. Weber S., Mawdsley E., Kaye D. Antibacterial agents in the elderly. Infect Dis Clin North Am 2009, 23(4):881-898. viii.
112. Heinlen L., Ballard J.D. Clostridium difficile infection. Am J Med Sci 2010, 340(3):247-252.
113. Shah D., Dang M.D., Hasbun R., et al. Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther 2010, 8(5):555-564.
114. Simor A.E. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. JAm Geriatr Soc 2010, 58(8):1556-1564.
115. Vesteinsdottir I., Gudlaugsdottir S., Einarsdottir R., et al. Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study. Eur J Clin Microbiol Infect Dis 2012, 31:2601-2610.
116. Cunningham R., Dial S. Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?. JHosp Infect 2008, 70:1-6.
117. Miller M., Gravel D., Mulvey M., et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010, 50:194.
118. Wenisch J.M., Schmid D., Tucek G., et al. Aprospective cohort study on hospital mortality due clostridium difficile infection. Infection 2012, 40:479-484.
119. Bauer M.P., Kujiper E.J., Van Dissel J.T., et al. European Society of Microbiology and Infectious Diseases (ESCMID): treatment guidance document for clostridium difficile infection (CDI). Clin Microbiol Infect 2009, 15:1067-1079.
120. Louie T.J., Miller M.A., Mullane K.M., et al. Fidaxomicin versus vancomycin for clostridium difficile infections. NEngl J Med 2011, 364:422-431.
121. Louie T.J., Cannon K., Byrne B., et al. Fidaxomicin preserves the instestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin Infect Dis 2012, 55:S132-S142.
122. Cornely O.A., Crook D.W., Esposito R., et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis 2012, 12:281-289.
123. Thiesemann R: Feststellung des Präventions- und Rehabilitationsbedarfes hochbetagter Pflegebedürftiger als gutachterliche Aufgabe, Schwerpunktseminar für Medizinische Gutachter des PKV-Verbandes, Berlin 2009; Übersetzung nach: Beschluss der United European Medical Societies - Geriatric Medicine Section (UEMS-GMS) am 3. Mai 2008 auf Malta.
124. Bauer T.T., Ewig S., Marre R., et al. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006, 260:93-101.